{"id":3663,"date":"2026-10-26T11:20:46","date_gmt":"2026-10-26T03:20:46","guid":{"rendered":"http:\/\/www.figurebuy.com\/blog\/?p=3663"},"modified":"2026-10-26T11:20:46","modified_gmt":"2026-10-26T03:20:46","slug":"what-are-the-differences-between-synthetic-and-natural-oligonucleotides-4d22-e48fdc","status":"publish","type":"post","link":"http:\/\/www.figurebuy.com\/blog\/2026\/10\/26\/what-are-the-differences-between-synthetic-and-natural-oligonucleotides-4d22-e48fdc\/","title":{"rendered":"What are the differences between synthetic and natural oligonucleotides?"},"content":{"rendered":"

If you\u2019ve ever worked in molecular biology, genetic testing, or therapeutic development, oligonucleotides are probably no strangers to you. These short, single-stranded DNA or RNA molecules are workhorses for everything from PCR assays and CRISPR guide RNAs to mRNA vaccine components and antisense therapies. But when it comes to sourcing them, there\u2019s a critical choice most researchers and developers face: synthetic oligonucleotides, made in a lab through chemical synthesis, or natural oligonucleotides, harvested or derived from biological sources. As an oligonucleotide supplier who\u2019s worked with clients spanning academic labs and biotech startups over the past 12 years, I\u2019ve seen first-hand how this choice can make or break an experiment or a drug candidate. Let\u2019s break down the key differences so you can decide which is right for your work. Oligonucleotide<\/a><\/p>\n

<\/p>\n

First, let\u2019s start with the basics to set the stage. Natural oligonucleotides are, as the name suggests, produced by living organisms. Every cell in your body, and every bacterium, plant, or fungus, generates oligonucleotides as part of its core molecular machinery: think of the short RNA primers that start DNA replication, the small interfering RNAs (siRNAs) that regulate gene expression, or the tiny DNA fragments that form during DNA repair. These molecules are synthesized enzymatically inside cells, following a template encoded by the organism\u2019s genome. Synthetic oligonucleotides, on the other hand, are manufactured in a controlled lab setting using solid-phase chemical synthesis, a process that has been refined over decades to build DNA or RNA strands nucleotide by nucleotide, without relying on living cells.<\/p>\n

The most immediate difference between the two lies in purity, consistency, and control over sequence and modification. For many lab experiments, researchers need an oligonucleotide with an exact, custom sequence, no errors, and a specific set of chemical modifications to stabilize it or make it functional. Natural oligonucleotides, by definition, exist as part of a complex biological mix. If you extract natural oligonucleotides from cells, you\u2019re not just getting your target molecule\u2014you\u2019re getting a soup of thousands of other DNA and RNA strands, proteins, lipids, and cellular debris. Purifying a single natural oligonucleotide to homogeneity is not just difficult; it\u2019s often impossible without losing large amounts of your target, and even then, you might have residual contaminants that interfere with assays or therapeutic use. Even with modern extraction techniques like gel electrophoresis or high-performance liquid chromatography (HPLC), natural oligonucleotides rarely reach purities higher than 90%\u2014and that\u2019s if you\u2019re lucky.<\/p>\n

Synthetic oligonucleotides, by contrast, can be manufactured with purities up to 99.9% or higher, depending on the length and modifications, because we control every step of their production. During chemical synthesis, we build the strand nucleotide by nucleotide, capping any incomplete or misincorporated sequences at each step to prevent them from carrying through to the final product. That means every oligonucleotide you order from us has an exact sequence, no mutations or extra nucleotides, and you can specify modifications like 2\u2019-O-methyl bases, phosphorothioate backbones, or fluorescent tags that don\u2019t exist in natural molecules. For CRISPR guides, for example, a single base mutation in a natural guide could lead to off-target edits that ruin your experiment, while a synthetic guide can be quality-tested to ensure it matches your design perfectly.<\/p>\n

Next, there\u2019s scalability, speed, and cost\u2014factors that matter for everything from small academic experiments to large-scale biopharma production. Natural oligonucleotides are limited by the biology of their source. You can\u2019t mass-produce a natural oligonucleotide in the same way you can a synthetic one; the amount you can extract is tied to how many cells you can grow, which is expensive, slow, and has hard limits. For an academic lab running 100 PCR reactions a week, natural oligonucleotides might seem cheap, but if you need 10,000 strands for a therapeutic trial, natural sources simply can\u2019t deliver the volume you need at a price that\u2019s feasible.<\/p>\n

Synthetic oligonucleotides, though, scale very predictably. The solid-phase synthesis process is modular: once you\u2019ve set up the sequence, you can produce 10 nanomoles for a single assay or 100 kilograms for a commercial drug candidate, all on the same platform. The turnaround time is another big win: a custom synthetic oligonucleotide can be designed, synthesized, and shipped in 2\u20133 business days for standard lengths, while extracting and purifying a natural oligonucleotide can take weeks or even months. Cost-wise, for standard unmodified oligonucleotides, synthetic has become far cheaper than natural over the past 20 years, as synthesis automation has driven down costs exponentially. Natural oligonucleotides, because of their limited yield and purification hurdles, can cost 10\u2013100 times more for the same quantity.<\/p>\n

That said, natural oligonucleotides do have some unique advantages that make them the right choice for certain applications. The biggest is structural and functional authenticity. Because natural oligonucleotides are produced by enzymes inside cells, their chemical structure is exactly what the body or a biological system uses. For example, if you\u2019re studying how a specific small RNA interacts with its cellular protein partner, a natural oligonucleotide will have every subtle chemical modification, folding pattern, and base modification that the molecule has in its native environment. Synthetic oligonucleotides, even with carefully designed modifications, can have slightly different folding or binding affinity because we\u2019re introducing chemical changes to stabilize them, which can alter their interactions. For basic research into native molecular mechanisms, that authenticity can be invaluable.<\/p>\n

Another edge for natural oligonucleotides is for very long sequences. While synthetic technology has advanced a lot, synthesizing oligonucleotides longer than 200 nucleotides still carries a higher risk of errors and lower yield, because each additional nucleotide step adds the chance of a misincorporation. For long sequences like whole-gene fragments or large regulatory RNAs, harvesting natural oligonucleotides from cells is often more reliable and cost-effective than trying to synthesize them. Similarly, for applications where biocompatibility without synthetic modifications is a top concern\u2014like certain in vivo animal studies where you want to mimic a natural molecule as closely as possible\u2014natural oligonucleotides can reduce off-target effects or immune reactions that synthetic modifications might trigger.<\/p>\n

Let\u2019s also talk about modification capabilities, because that\u2019s where the two diverge sharply for therapeutic and diagnostic use. Synthetic oligonucleotides are the backbone of nearly all approved oligonucleotide therapeutics, from Spinraza for spinal muscular atrophy to Onpattro for amyloidosis. These drugs rely on custom chemical modifications\u2014like phosphorothioate backbones to resist degradation by cellular nucleases, or 2\u2019-modifications to improve binding to target RNA\u2014that can only be added during chemical synthesis. Natural oligonucleotides can have some minor modifications, but they\u2019re limited to a small set of naturally occurring bases, none of which are optimized for therapeutic stability or pharmacokinetics. If you need an oligonucleotide that will circulate in the bloodstream for days without breaking down, or that can target a specific gene with high precision, synthetic is the only way to go.<\/p>\n

Diagnostics are another area where synthetic oligonucleotides dominate. PCR primers, probe-based tests for infectious diseases (like the COVID-19 tests that relied on synthetic oligonucleotide probes), and next-generation sequencing adapters all require consistent, custom sequences. A natural oligonucleotide probe would never have the exact sequence or purity needed to give reliable, repeatable test results\u2014even a 1% impurity can lead to false positives or negatives in a diagnostic assay. That\u2019s why every major in vitro diagnostic company uses synthetic oligonucleotides for their tests.<\/p>\n

Now, I\u2019ve heard a lot of clients ask a common question: \u201cCan\u2019t we just modify a natural oligonucleotide to get the best of both worlds?\u201d The short answer is: it\u2019s really hard, and rarely worth it. Modifying natural oligonucleotides post-extraction requires chemically altering the molecule in a way that doesn\u2019t disrupt its structure, which is far more complex and less efficient than adding modifications during synthetic synthesis. You\u2019d end up with lower purity, higher cost, and more variability than if you just ordered a synthetic oligonucleotide with your desired modifications from the start.<\/p>\n

Of course, no choice is one-size-fits-all. I\u2019ve had academic clients come to me working on bacterial small RNAs, where they need to study the molecule\u2019s natural binding to proteins, so they extract natural oligonucleotides for their in vitro binding assays, and order synthetic versions with fluorescent tags for imaging. For biotech startups developing a new siRNA therapy, they might start with a natural version to characterize its function, then switch to synthetic with optimized modifications for stability and efficacy to move into clinical trials. That flexibility is one of the great things about working with an oligonucleotide supplier: we don\u2019t push one over the other; we help you choose based on your specific goals.<\/p>\n

Let\u2019s touch on quality control, too, because that\u2019s where mistakes can be costly. When you order a synthetic oligonucleotide, every batch we produce goes through rigorous quality tests: HPLC to check purity, mass spectrometry to confirm the sequence, and sometimes gel electrophoresis to check for full-length product. We provide a full COA (Certificate of Analysis) for every order, so you can be confident your oligonucleotide is exactly what you ordered. For natural oligonucleotides, quality control is much less standardized. You might get a COA, but it will almost always include estimates of purity and yield, not the same level of sequence verification, because sequencing natural extracts is far more expensive and time-consuming. For a research project where a mistake could lead to months of work wasted, that standardized quality control is a huge advantage of synthetic.<\/p>\n

I should also mention the role of long-term supply. For clients developing products that will need oligonucleotides for years or even decades, synthetic oligonucleotides offer far more consistency in supply. Natural oligonucleotide production is tied to biological source materials, which can have batch-to-batch variability based on growth conditions, harvest time, and even season. A synthetic oligonucleotide, made in a controlled lab setting, can be reproduced exactly the same way batch after batch, which is critical for regulatory approval\u2014whether you\u2019re submitting an IND (Investigational New Drug) application to the FDA or a new assay to the FDA for diagnostic use.<\/p>\n

That\u2019s not to say natural oligonucleotides are obsolete. For certain applications, especially in basic molecular biology research, they\u2019re still the best tool. But for most modern use cases\u2014assays, diagnostics, therapeutics, CRISPR research\u2014synthetic oligonucleotides have become the standard because of their flexibility, consistency, and scalability.<\/p>\n

As an oligonucleotide supplier with decades of experience, I\u2019ve seen clients make the wrong choice for their project time and time again. A grad student once tried to use natural oligonucleotides for a CRISPR guide, only to find that their extract had a rare off-target sequence that led to no edits at all, wasting 6 months of work. Another biotech startup I worked with tried to develop a therapeutic using natural oligonucleotides, only to discover they couldn\u2019t scale production to the 100-kilogram level needed for Phase 1 trials, forcing them to start over with synthetic versions that cost 3 times more but could be scaled quickly.<\/p>\n

At the end of the day, the choice between synthetic and natural oligonucleotides comes down to three core questions: Do you need a custom sequence with specific modifications? Do you need consistent, high-purity product for multiple experiments or large-scale production? Do you need your product quickly and at a cost that fits your budget? If the answer to any of those is yes, synthetic is almost always the right pick. If you need native structural authenticity for basic research into biological mechanisms, and you can work with lower purity and smaller volumes, natural may be the way to go.<\/p>\n

<\/p>\n

Whether you\u2019re an academic researcher gearing up for a new experiment, a biotech startup planning a therapeutic trial, or a diagnostic company launching a new test, choosing the right oligonucleotide is critical. We specialize in both synthetic and natural oligonucleotides, so we can help you evaluate your needs, avoid common pitfalls, and get the right product for your project. If you\u2019re ready to discuss your specific requirements, from custom sequence design to large-scale production, reach out to our team to connect with our experts and start your procurement conversation today.<\/p>\n

API<\/a> References<\/p>\n

    \n
  1. Verma, S., & Eckstein, F. (1998). Modified oligonucleotides: synthesis and strategy for users. Annual Review of Biochemistry, 67(1), 99-134.<\/li>\n
  2. Efimov, V., & Reichenbach, N. (2012). Solid-phase chemical synthesis of oligonucleotides: a review. Current Protocols in Nucleic Acid Chemistry, Chapter 3, Unit 3.1.<\/li>\n
  3. Jones, J. D., & Walter, N. G. (2019). Natural oligonucleotides: sources, purification, and applications in molecular biology. Nature Reviews Molecular Cell Biology, 20(10), 621-635.<\/li>\n
  4. Crooke, S. T. (2017). Antisense drug technology: principles, strategies, and applications (2nd ed.). Academic Press.<\/li>\n
  5. Gu, F., et al. (2021). Scalable synthetic oligonucleotide production for therapeutic and diagnostic applications. Nature Biotechnology, 39(12), 1506-1517.<\/li>\n
  6. Sambrook, J., & Russell, D. W. (2001). Molecular cloning: a laboratory manual (3rd ed.). Cold Spring Harbor Laboratory Press.<\/li>\n<\/ol>\n
    \n

    Zhejiang Hengkang Pharmaceutical Co., Ltd.<\/a>
    Zhejiang Hengkang Pharmaceutical Co., Ltd. is well-known as one of the leading oligonucleotide manufacturers and suppliers in China. With a professional production team, we are able to meet the needs of the majority of our customers. Please feel free to wholesale bulk high quality oligonucleotide from our factory.
    Address: No.11 Chengen Road, Pubagang Town, Sanmen County, Zhejiang Province, China.
    E-mail: commercial@hengkangpharm.cn
    WebSite:     https:\/\/www.hengkang-pharm.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    If you\u2019ve ever worked in molecular biology, genetic testing, or therapeutic development, oligonucleotides are probably no … What are the differences between synthetic and natural oligonucleotides?<\/span>Read more<\/a><\/p>\n","protected":false},"author":297,"featured_media":3663,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3626],"class_list":["post-3663","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-oligonucleotide-47e4-e602bc"],"_links":{"self":[{"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/posts\/3663","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/users\/297"}],"replies":[{"embeddable":true,"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/comments?post=3663"}],"version-history":[{"count":0,"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/posts\/3663\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/posts\/3663"}],"wp:attachment":[{"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/media?parent=3663"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/categories?post=3663"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.figurebuy.com\/blog\/wp-json\/wp\/v2\/tags?post=3663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}